Note table 3 does not include the 3.0mg and 4.5mg of dulaglutide, which lower A1c by 1.6% and 1.8% respectively (285)
Younger participants in the 25 to 40 age range tended to report fewer GI side effects and showed slightly faster adaptation during the dose escalation phase
6 This shift was in response to previously approved T2D medications subsequently demonstrating neutral or harmful cardiovascular effects
Sanyal Hepatology .2026;[Epub] CrossRef MASHRelated Liver Cancer Estimates Need AetiologySpecific Validation in the AsiaPacific Region Haoyang Hu Liver International .2026;[Epub] CrossRef Liver fibrosis in metabolic dysfunction-associated steatotic liver disease: epidemiology, risk stratification and therapeutics Fuliang Li, Hongmei Li, Dulguun Juramt, Kai Kou, Frank Tacke, Lanlan Chen BMJ Open Gastroenterology .2026
The gut microbiome modulates the protective association between a Mediterranean diet and cardiometabolic disease risk
Several drugs have been widely touted of late for promoting weight loss and lowering high blood sugar
